DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Bismuth H.
Comparison of FK 506- and cyclosporine-based immunosuppression: FK 506 therapy significantly reduces the incidence of acute, steroid-resistant, refractory, and chronic rejection whilst possessing a comparable safety profile. European FK 506 Multicenter Liver Study Group.
Transplant Proc 1995;
27 (01) 45-49
Access:
We do not assume any responsibility for the contents of the web pages of other providers.